本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Nautilus Biotechnolgy, Inc.

0.7070
+0.03705.52%
盘后0.6963-0.0107-1.51%16:57 EDT
成交量:64.72万
成交额:46.90万
市值:8,929.77万
市盈率:-1.36
高:0.7500
开:0.7300
低:0.7000
收:0.6700
52周最高:3.09
52周最低:0.6200
股本:1.26亿
流通股本:4,627.91万
量比:1.69
换手率:1.40%
股息:- -
股息率:- -
每股收益(TTM):-0.5217
每股收益(LYR):-0.5643
净资产收益率:-31.55%
总资产收益率:-19.30%
市净率:0.49
市盈率(LYR):-1.25

数据加载中...

2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/02

重要事件披露

8-K - Current report
2021/11/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/26

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/22

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/10

重要事件披露

8-K - Current report
2021/06/08

企业合并公告

425 - Prospectuses and communications, business combinations
2021/06/08

重要事件披露

8-K - Current report
2021/06/01

重要事件披露

8-K - Current report